EV Biologics Corp, (OTC PINK:YECO), today announced that it is initiating a PCAOB audit for 2021 and 2022 and intends to file an application to list on the OTCQX market during Q1, 2023. This PCAOB audit is a necessary step...
Press Releases
EV Biologics Launches Excyte with $100 million Valuation
EV Biologics Corp, OTC Pink: YECO, today announced that it has launched Excyte, Inc., a wholly owned subsidiary, with $100 Million valuation. Excyte has already raised $500,000 of its $2.5 million initial capitalization goal. This funding will initially provide scale-down...
EV Biologics Signs MSA with LONZA Cell & Gene Therapy
EV Biologics Corp, OTC PINK:YECO, today announced that it has signed a Manufacturing Services Agreement (MSA) with Lonza for development of stem/progenitor cell-derived nanotherapeutics and scalable biomanufacturing process. The MSA enables EV Biologics to accelerate its nanotherapeutic biomanufacturing process and...